Cellular proliferation in complicated versus uncomplicated atherosclerotic lesions: Total cell population, foam cells and newly formed microvessels

Tissue and Cell

Volumn 41, Issue 6, 2009, Pages 408-413

  Manolakou, P ^a   Angelopoulou, R ^a   Bakoyiannis, C ^a   Psathas, E ^a   Bastounis, E ^a   Kavantzas, N ^a   Patsouris, E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Atheroclerosis; Carotid plaques; Cellular proliferation; Foam cells; Neovascularization; PCNA

Indexed keywords

CYCLINE;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CELL POPULATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FOAM CELL; HUMAN; HUMAN TISSUE; MICROVASCULATURE;

EID: 70449531507     PISSN: 00408166     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tice.2009.05.003     Document Type: Article

References (25)

1. Aherne W.A., and Dunnill M.S. Morphometry (1982), Edward Arnold Publishers, London pp. 24-26
2. Balla M., Angelopoulou R., Lavranos G., and Manolakou P. Gonadal cell proliferation dimorphism. Coll. Anthropol. 30 (2006) 643-648
3. Balla M., Angelopoulou R., Lavranos G., and Kittas C. Follicular cells versus oocytes cell population dynamics in the developing ovary. Tissue Cell 40 (2008) 373-381
4. Bravo R., Frank R., Blundell P.A., and Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature 326 (1987) 515-517
5. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 337 (1991) 1235-1243
6. Geng Y., and Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1370-1380
7. Gordon D., Reidy M.A., Benditt E.P., and Schwartz S.M. Cell proliferation in human coronary arteries. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 4600-4604
8. Hall P.A., Levison D.A., Woods A.L., Yu C.C.-W., Kellock D.B., Watkins J.A., Barnes D.M., Gillett C.E., Camplejohn R., and Dover R. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol. 162 (1990) 285-294
9. Jaskulski D., deRiel J.K., Mercer W.E., Calabretta B., and Baserga R. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin. Science 240 (1988) 1544-1546
10. Katsuda S., Coltrera M.D., Ross R., and Gown A.M. Human atherosclerosis. IV. Imunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am. J. Pathol. 142 (1993) 1787-1793
11. Lavezzi A.M., Milei J., Grana D.R., Flenda F., Basellini A., and Matturri L. Expression of c-fos, p53 and PCNA in the unstable atherosclerotic carotid plaque. Int. J. Cardiol. 92 (2003) 59-63
12. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
13. Libby P., and Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat. Med. 8 (2002) 1257-1262
14. Moulton K.S. Angiogenesis in atherosclerosis: gathering evidence beyond speculation. Curr. Opin. Lipidol. 17 (2006) 548-555
15. Newby A.C., and Zaltsman A.B. Fibrous cap formation or destruction-the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc. Res. 41 (1999) 345-360
16. Nichols A.F., and Sancar A. Purification of PCNA as a nucleotide excision repair protein. Nucl. Acids Res. 20 (1992) 2441-2446
17. Norrby K. Angiogenesis: new aspects relating to its initiation and control. APMIS 105 (1997) 417-437
18. O'Brien E.R., Alpers C.E., Stewart D.K., Ferguson M., Tran N., Gordon D., Benditt E.P., Hinohara T., Simpson J.B., and Schwartz S.M. Proliferation in primary and restenotic coronary atherectomy tissue. Circ. Res. 73 (1993) 223-231
19. Orekhov A.N., Andreeva E.R., Mikhailova I.A., and Gordon D. Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich regions. Atherosclerosis 139 (1998) 41-48
20. Pickering J.G., Weir L., Kekanowski J., Kearney M.A., and Isner J.M. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J. Clin. Invest. 91 (1993) 1469-1480
21. Pipp F., Heil M., Issbrucker K., Ziegelhoeffer T., Martin S., van den Heuvel J., Weich H., Fernandez B., Golomb G., Carmeliet P., Schaper W., and Clauss M. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ. Res. 92 (2003) 378-385
22. Rekhter M.D., and Gordon D. Does platelet-derived growth factor-A chain stimulate proliferation of arterial mesenchymal cells in human atherosclerotic plaques?. Circ. Res. 75 (1994) 410-417
23. Rekhter M.D., and Gordon D. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am. J. Pathol. 147 (1995) 668-677
24. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov S., Insull W., Rosenfeld M.E., Schwartz C.J., Wagner W.D., and Wissler R.W. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation 92 (1995) 1355-1374
25. Vukovic I., Arsenijevic N., Lackovic V., and Todorovic V. The origin and differentiation potential of smooth muscle cells in coronary atherosclerosis. Exp. Clin. Cardiol. 11 (2006) 123-128